Objective: The aim of this study was to determine the impact of gynecologic 51 surgeon volumes on patient outcomes. 52
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In his popular book Outliers 1 , Malcolm Gladwell famously argued that the mastering 101 of any skill requires 10 000 hours, or twenty hours a week for ten years, of deliberate 102 practice. It seems a feasible theory that to obtain a skill with a repetitive technique, 103 be it surgery or landing a plane, recurrent practice is required. In Australia, airline 104 pilots for example, are required to land at least three times every 90 days to maintain 105 their proficiency certificates 2 . 106
In many surgical fields the relationship between surgical volume and outcome is well 107
established. An American study of greater than 470 000 Medicare patients 108 undergoing either cardiovascular procedures or cancer resections found that the 109 operative mortality rate was strongly and inversely related to surgeon volume for 110 each procedure. 3 
111
Several papers have examined this relationship in the field of gynecology, 112 specifically looking at mid-urethral slings 4, 5 , pelvic reconstructive procedures 6 , 113 hysterectomies for benign indications [7] [8] [9] [10] [11] , myomectomies 12,13 and gynecologic-114 oncological procedures [14] [15] [16] [17] [18] [19] [20] [21] and have reported conflicting results. A 2013 review 115 article, without meta-analysis, of surgeon volumes and outcomes for benign 116 hysterectomy concluded that morbidity was higher for low volume surgeons and high 117 volume surgeons were more efficient 22 . 118
The lifetime risk of undergoing major gynecologic surgery in many developed 119 countries is in the order of 15-40%. 23, 24, 25 Estimating the association between 120 adverse outcomes and risk factors that can potentially be addressed through 121 practice or policy changes, such as surgeon volume, is an important public health 122 concern.
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We performed a systematic review and meta-analysis to determine if gynecologic 124 surgeon volumes impacted upon patient outcomes. Our null hypothesis is that 125 surgeon volume had no impact on surgical outcomes or surgical efficiency. 126
Methods 127
Eligibility 128
Eligible studies were selected through an electronic literature search from inception 129 up until September 2015 using Pubmed, the Cochrane Central Register of Controlled 130
Trials, the Cochrane Database of Systematic Reviews, Medline and clinicaltrials.gov. 131
Search terms included the following keywords "surgical volume," "surgeon volume," 132 "low-volume OR high-volume," "gynecology OR hysterectomy OR sling OR pelvic 133 floor repair OR continence procedure". There were no exclusion criteria for language 134 or geographic location. Additional records were identified from references of articles 135 identified through database searching 136
Study Selection 137
The literature search was conducted in accordance with the Preferred Reporting 138
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and 139 included prospective and retrospective studies that compared surgical complications 140 or markers of surgical efficiency between high volume surgeons (HVS) and low 141 volume surgeons (LVS) for any major gynecological procedure. All the studies 142 involved women over 18 years of age undergoing major gynecological surgery. We 143 defined a low volume surgeon as one performing the procedure once a month or 144 less (twelve or less procedures a year) and studies were excluded if their definition 145 of a LVS was > +/-33% of our definition (range 8 to 16). Studies which divided 146 surgeons into low, medium and high volume surgeons were included if two of the 147 groups could be merged to fit our inclusion criteria.
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Mowat, A Primary outcomes were total complications, intraoperative complications and/or post-149 operative complications. Secondary outcomes were mortality, medical complications, 150 cystotomy, ureteric injury, bowel injury, vascular injury, transfusion rates, operating 151 time, length of stay, estimated blood loss, readmission rates and reoperation rates. 152
For the primary outcome of total complications, studies were included if they 153 provided data for an outcome of "total complications", "total morbidity" or "any 154 
Data extraction and analysis 166
Data extraction was undertaken independently by two reviewers to ensure accuracy. 167
If disagreement occurred a decision was made by mutual agreement. Outcome data 168 for individual studies were entered into Review Manager 5.3 systematic review 169 software. When two or more studies evaluated a designated outcome meta-analysis 170 was performed as per the Cochrane methodology. For analysis of the categorical 171 variables we calculated the odds ratio (OR; odds of women with a certain outcome in 172 relation to the odds of women without the outcome in the group). For continuousM A N U S C R I P T
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Unless otherwise stated the outcomes in this meta-analysis were calculated from the 175 raw data reported in the papers and presented without adjustment for confounders. 176
Where possible, adjusted odds ratios and risk ratios were combined to give 177 outcomes adjusted for possible confounders, including patient age, body mass index 178 (BMI) and co-morbidities. If there was significant heterogeneity in the outcomes 179 recorded in different studies as defined by the I 2 calculation being greater than 75%, 180 a random effects model was used, otherwise a fixed-effect model was used for the 181 calculation of summary estimates and their 95% confidence intervals (CI). Data 182 analysis was entered into GRADEpro software, which generated a Summary of 183
Findings (SOF) table that included structured and qualified grading (very low to high) 184 of the quality for the evidence of the individual outcomes and provided a measure of 185
effect. 186
Results
187
Study selection and characteristics 188
A total of 2151 abstracts met the initial search criteria. Of those 2123 were excluded 189 by reviewers because they did not meet the pre-defined criteria. Twenty-eight full 190 articles were assessed for eligibility and 14 were excluded for not meeting the 191 defined inclusion criteria as outlined in the PRISMA flow study. (Fig 1) . Fourteen 192 peer-reviewed studies from three countries (The Netherlands, The United States of 193 America and Canada) with a total of 741 760 patients were included in the 194 systematic review. The two urogynecology studies were unable to be combined and 195 so twelve studies were combined in meta-analysis. Two studies (Wallenstein, Gupta) potentially included the same patients from the Premier In the gynecology group five studies evaluated hysterectomy 7,8,9,10,11 and two 202 evaluated myomectomy 12, 13 . In the gynecologic oncology group three studies 203 reported on endometrial cancer 14,15,16 and two on ovarian cancer 16, 17 . In the 204 urogynecology group one study evaluated pelvic reconstructive surgeries 6 and 205 another evaluated reoperation rates after mid-urethral sling surgery 5 . 206
Patient characteristics including age and co-morbidities were reported in nine of the 207 14 articles and in six studies 5,7,9,11,13,15 the HVS group had older women and/or 208 women with more co-morbidities, in one study the LVS group had older women with 209 more co-morbidities 8 and in two studies the pre-intervention groups were similar 12,14 . 210 Table 1 . 211
Synthesis of results 212
Low volume surgeon versus high volume surgeon and outcomes in 213
gynecology. 214
Total in-hospital complications 215
Low volume surgeons had a higher rate of total in-hospital complications than high 216 volume surgeons as reported in four studies 7,8,10,11 ; OR 1.3 95% CI 1.2 to 1.5, SOF 217
Table1. This means that if in-hospital complications occur in 97 per 1000 patients in 218 the HVS group, between 114-137 per 1000 patients in the LVS group would develop 219 in-hospital complications. Two studies 10,11 provided data for total in-hospital 220 complications adjusted for age and comorbidities and the increased risk of any in-221 hospital complication in the LVS group was slightly greater; OR 1.4 95% CI 1.3 to 222 1.5, SOF Table 1 . On a number needed to treat analysis this translated to one in-223 M A N U S C R I P T
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Mowat, A hospital complication being avoided for every 30 operations that were performed by 224 a high volume surgeon rather than a low volume surgeon. Hanstede 11 re-analysed 225 their data excluding gynecologic oncologists and reported a greater difference 226 between the LVS and HVS groups OR of 2.8 95% CI 2.1 to 3.6, adjusted for age and 227 comorbidities. On a number needed to treat analysis this translated to one in-228 hospital complication being avoided for every 10 operations that are performed by a 229 high volume surgeon rather than a low volume surgeon. 230
Intraoperative complications 231
Three studies ,8,10,11 reported on this outcome and the LVS group had a higher rate of 232 intraoperative complications compared with the HVS group; OR 1.6 95% CI 1.2 to 233 2.1, SOF Table 1 . This means that if intraoperative complications occur in 22 per 234 1000 patients in the HVS group, between 26-45 per 1000 patients in the LVS group 235 would develop intraoperative complications. Two studies 9,11 calculated an OR 236 adjusted for age and comorbidities and a further increase in the risk of intraoperative 237 complications was seen in the LVS group compared to the HVS group; OR 1.8 95% 238 CI 1.1 to 3.2, SOF Table 1 . On a number needed to treat analysis this translates to 239 one intraoperative complication being avoided for every 38 operations that are 240 performed by a high volume surgeon rather than a low volume surgeon. 241
Hanstede 11 re-analysed their data, without gynecologic oncologists, and the greater 242 risk of intraoperative complications in the LVS group was more evident; OR 3.4 95% 243 CI 2.0 to 5.9, SOF Table 1 . On a number needed to treat analysis this translates to 244 one intraoperative complication being avoided for every 20 operations that are 245 performed by a high volume surgeon rather than a low volume surgeon. 246 by a high volume surgeon rather than a low volume surgeon. 257
Postoperative complications 247
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Hanstede 11 re-analysed, without gynecologic oncologists, and the difference 258 between the two groups was more pronounced; OR 2.4 95% CI 1.8 to 3.2, SOF 259 Table 1 . On a number needed to treat analysis this translates to one postoperative 260 complication being avoided for every 15 operations that are performed by a high 261 volume surgeon rather than a low volume surgeon. 262
Mortality 263
There was no difference in mortality between the two groups. 264
Medical complications 265
Three studies 8,9,10,11 reported on medical complications and found that medical 266 complications were more common in the LVS group compared with the HVS group; 267 OR 1.6 95% CI 1.5 to 1.6, SOF Table 2 Urinary tract injury (ureteric and bladder injury combined) was reported in three 275 studies 8,10,11 and was more likely in the LVS group; OR 1.4 95% CI 1.1 to 1.9, SOF 276 Table 2 . 277
There was no difference in risk of cystotomy or vascular injury, SOF Table 2 . 278
Operating time 279
Four studies 7,11,12,13 reported on this outcome and found that operating time was 280 longer in the LVS group; MD 17.7 minutes 95% CI 10.4 to 25.0, SOF Table 2 . 281
Estimated blood loss and transfusion rates 282
Two studies 7,13 reported that estimated blood loss was greater in the LVS group; MD 283 59.3 ml 95% CI 32.0 to 86.6mls, SOF Table 2 . There was no difference in 284 transfusion rates. 285
Length of stay 286
There was no difference in mean length of stay between the HVS group and the LVS 287 group. Wallenstein 8 found that women in the LVS group were more likely to stay in 288 hospital for over two days; OR 1.4 95% CI 1.3 to 1.4, SOF Table 2 
Readmission rates 292
Readmission rates were reported in three studies 7,9,11 and were lower for the LVS 293 group; OR 0.8 95%CI 0.7 to 0.9, SOF Table 2 . This means that if 20 in 1000 patients 294 are readmitted in the HVS group, 14-18 in 1000 patients would be readmitted in the 295 LVS group. 296 M A N U S C R I P T
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Reoperation rates 297
There was no difference in reoperation rates. 298
Low volume surgeon versus high volume surgeon and outcomes in 299
gynecologic oncology. 300
Mortality 301
Mortality was reported in four studies 14, 15, 16, 18 and was higher in the LVS group 302 compared with the HVS group; OR 1.9 95% CI 1.3 to 2.6, SOF Table 3 . This means 303 that if the mortality rate is 7 per 1000 patients in the HVS group, the rate would be 304 between 9-18 per 1000 in the LVS group. Three of these studies 14,16,18 adjusted the 305 outcomes for age and comorbidities and the difference between the two groups 306 became more significant; OR 2.5 95% CI 1.7 to 3.8, SOF 
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Length of Stay 322
A single study by Wright 15 looked at this outcome and found that patients in the LVS 323 group were more likely to stay over two days when compared with patients in the 324 HVS group; OR 1.3 95% CI 1.1 to 1.6, SOF Table 3 . 325
Transfusion rates 326
Two studies 14,15 reported on this outcome and found that blood transfusions were 327 required more often in the HVS group than in the LVS group; OR 0.7 95% CI 0.6 to 328 0.8. This means that if transfusions are required in 71 per 1000 patients in the HVS 329 group, they would be required in between 43-60 per 1000 patients in the LVS group, 330 SOF Table 3 . 331
5-year survival 332
Vernooij 17 looked at 5-year survival in ovarian cancer patients. Results were 333 presented as hazard ratios adjusted for age and stage of cancer and it was reported 334 that surgery by a HVS reduced mortality by 29% (HR 0.7 95% CI 0.5-1.0). 335
Low volume surgeon versus high volume surgeon and outcomes in 336
urogynecology. 337
Due to the heterogeneity of both datum format and outcomes, we were unable to 338 combine the two studies in this group. One study by Sung 6 evaluated the impact of 339 low versus high volume surgeons on complications in pelvic reconstructive surgery. 340
Raw data was not presented in this paper and was not able to be provided by author 341 when contacted by email. Thus we were unable to combine the findings of this study 
Main Findings 365
We demonstrated a 30% increase in the risk of experiencing any in-hospital 366 complication, a 60% increase in the risk of incurring an intraoperative complication, a 367 40% increase in the risk of incurring an in-hospital postoperative complication in 368 gynecology, and a 90% increase in the mortality rate for gynecologic oncology in the 369 LVS group as compared with the HVS group. After adjusting for possible 370 confounders the magnitude of the effect between high and low volume surgeons was 371 M A N U S C R I P T
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Mowat, A increased such that there was a 40% increase in the risk of experiencing any in-372 hospital complication, an 80% increase in the risk of incurring an intraoperative 373 complication, a 50% increase in the risk of incurring an in-hospital postoperative 374 complication in gynecology and a 250% increase in the mortality rate for gynecologic 375 oncology. This implies that HVS operate on patients with greater morbidities. 376
Interestingly, in Wallenstein 8 it was the low volume surgeon group which had the 377 older and sicker patients. In that study a multivariate analysis was undertaken 378 adjusting for patient characteristics and when they adjusted for these differences, In the urogynecology group we demonstrated a 37% increase in the risk of 387 reoperation for mesh complications after mid-urethral sling procedure in the LVS 388 group compared with the HVS group. 389
While these findings are clinically relevant to the patient, some of our findings, 390 although statistically significant, may not be clinically relevant. For example, in the 391 gynecology group, a higher blood loss in the LVS group of 60mls is not of clinical 392
relevance. 393
Strengths and Limitations 394
The strengths of this study are the large numbers and that data was collected from 395 government databases which increased the strength and reliability of the data. The 396 M A N U S C R I P T
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Mowat, A data from such databases are samples and are frequently without patient-specific 397 identifiers, meaning that the complication and the operation cannot be reliably linked. 398
However these concerns are nullified by the original trial methodologies ensuring 399 that any impact of this equally affects both the control and the intervention group. 400
A weakness of the paper is that the data only captures complications that are 401 managed in hospital and so is likely to underestimate the true incidence of 402 complications related to gynecologic surgery. However you would expect that the 403 more serious complications, that by their very nature require readmission, would be 404 captured. Five of the 14 studies failed to adjust for patient comorbidities as possible 405 confounders. When possible, adjusted data was combined in meta-analysis, 406 however the evidence would be strengthened if all studies had adjusted for possible 407 confounders. Only two studies in this group evaluated urogynecology and, although 408 the patient number is very large, this may limit the generalisability of our findings. 409
The authors accept that by allowing a range of values for the high and low volume 410 surgeon cut-off there may be an under-estimation of the volume-outcome effect at 411 the upper limit and an over-estimation at the lower limit. Large population based 412 studies retrieving data retrospectively appear to be the only reasonable avenue for 413 sourcing data on complication outcomes with a relatively low incidence. GRADEpro 414 rates all retrospective data as a priori "low grade" and downgrades it to "very low" 415 based on risk of bias, inconsistency, indirectness, imprecision, and publication bias, 416
and upgrades it to "moderate" based on large effect, plausible confounders and dose 417 response gradient. Randomised controlled trials would provide a higher grade of 418 evidence however, based on the present data, these may be unethical and 419 impractical. While this evidence is graded from very low to moderate resulting in 420 M A N U S C R I P T
Mowat, A some uncertainty regarding the findings for the reasons outlined above, it is unlikely 421 that a higher grade of evidence will become available. performing the procedure at least ten times a year, a definition which is compatible 447 with our own. 28 
448
Conclusion and implications 449
There is significant morbidity in patients following gynecology surgery, with 10% of 450 all patients reporting in-hospital complications in this meta-analysis. Surgeons 451
performing procedures approximately once a month or less (range 8-16 procedures 452 a year) had higher rates of adverse outcomes in gynecology, gynecologic oncology 453 and urogynecology and a higher mortality rate and lower 5-year survival outcomes in 454 gynecologic oncology. While the grade of evidence for the majority of primary 455 outcomes is moderate, it is very low to low for most of the secondary outcomes, and 456 this should be reflected if this data were to be utilised for the formulation of 457 guidelines relating to the performance of gynecologic surgery. 458
This systematic review and meta-analysis finds that surgeon volume is an important 459 factor in surgical outcomes in gynecology. In the United States of America the 460 mounting evidence linking surgeon and hospital volume to patient outcomes, 461 including mortality, has led to initiatives which encourage patients to choose high 462 volume surgeons and hospitals for elective procedures. 29 An example of this is the 463 Leapfrog Group for Patient Safety, a national consortium of private and public 464 purchasers of health insurance, which produces a website encouraging patients to 465 choose a surgeon and a hospital with procedure-specific experience. 30 There is 466 literature indicating that high volume surgeons are increasingly performing a larger 467 proportion of elective surgery 27 . 468
Further research is required to ensure that patient co-morbidities are fully controlled 469 for in the assessment of surgeon volume and outcomes, and to improve the 
